We have previously reported that the inhibition of MUC4 expression by antisense technique in the well-differentiated cancer cell line, CD18/HPAF, reduced tumorigenicity, and metastasis in vivo (Singh et al, 2004). The gene discussed is MUC4; the disease is cancer.